These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20439611)

  • 1. Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.
    Bobardt MD; Chatterji U; Schaffer L; de Witte L; Gallay PA
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2753-66. PubMed ID: 20439611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.
    Terrazas-Aranda K; Van Herrewege Y; Hazuda D; Lewi P; Costi R; Di Santo R; Cara A; Vanham G
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2544-54. PubMed ID: 18474579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
    Krebs FC; Miller SR; Malamud D; Howett MK; Wigdahl B
    Antiviral Res; 1999 Oct; 43(3):157-73. PubMed ID: 10551374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment.
    Latinovic OS; Zhang J; Tagaya Y; DeVico AL; Fouts TR; Schneider K; Lakowicz JR; Heredia A; Redfield RR
    Curr HIV Res; 2016; 14(1):24-36. PubMed ID: 26354735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus.
    Bobardt MD; Cheng G; de Witte L; Selvarajah S; Chatterji U; Sanders-Beer BE; Geijtenbeek TB; Chisari FV; Gallay PA
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5525-30. PubMed ID: 18378908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1.
    de Witte L; Bobardt M; Chatterji U; Degeest G; David G; Geijtenbeek TB; Gallay P
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19464-9. PubMed ID: 18040049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicides.
    Watson Buckheit K; Yang L; Buckheit RW
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5243-54. PubMed ID: 21896906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
    Traunecker A; Schneider J; Kiefer H; Karjalainen K
    Nature; 1989 May; 339(6219):68-70. PubMed ID: 2541344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anti-human immunodeficiency virus effect of recombinant CD4-immunoglobulin in vitro: a good candidate for AIDS treatment.
    Chowdhury IH; Koyanagi Y; Takamatsu K; Yoshida O; Kobayashi S; Yamamoto N
    Med Microbiol Immunol; 1991; 180(4):183-92. PubMed ID: 1784269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
    Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells.
    McElrath MJ; Ballweber L; Terker A; Kreger A; Sakchalathorn P; Robinson B; Fialkow M; Lentz G; Hladik F
    Antimicrob Agents Chemother; 2010 Feb; 54(2):763-72. PubMed ID: 19949052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.
    Latinovic OS; Medina-Moreno S; Schneider K; Gohain N; Zapata J; Pazgier M; Reitz M; Bryant J; Redfield RR
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):178-86. PubMed ID: 26059995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.
    Binley JM; Ngo-Abdalla S; Moore P; Bobardt M; Chatterji U; Gallay P; Burton DR; Wilson IA; Elder JH; de Parseval A
    Retrovirology; 2006 Jul; 3():39. PubMed ID: 16817962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.
    Vermeire K; Brouwers J; Van Herrewege Y; Le Grand R; Vanham G; Augustijns P; Bell TW; Schols D
    Curr HIV Res; 2008 May; 6(3):246-56. PubMed ID: 18473788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives.
    Vicenzi E; Gatti A; Ghezzi S; Oreste P; Zoppetti G; Poli G
    AIDS; 2003 Jan; 17(2):177-81. PubMed ID: 12545076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.
    Fletcher P; Harman S; Azijn H; Armanasco N; Manlow P; Perumal D; de Bethune MP; Nuttall J; Romano J; Shattock R
    Antimicrob Agents Chemother; 2009 Feb; 53(2):487-95. PubMed ID: 19029331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virion-surface display of a chimeric immunoglobulin Fc domain facilitating uptake by antigen-presenting cells.
    Seki S; Parbie PK; Yamamoto H; Matano T
    J Biotechnol; 2024 Aug; 391():57-63. PubMed ID: 38851397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.